Skip to main content
. 2022 Jul 25;10(8):e646. doi: 10.1002/iid3.646

Figure 1.

Figure 1

Level of SARS‐CoV‐2 Spike1 antibodies (U/ml) differentiated by vaccination types. The third column shows antibody levels in patients infected with SARS‐CoV‐2 after vaccinated two times. There was a significant difference between mRNA versus non‐mRNA vaccine‐induced immune response (p = .002), and antibody response is significantly higher (p < .05) in recovered patients after two doses of injections. All infected patients received mRNA vaccine. Three patients died due to COVID, their third antibody level is missing. As the primary immunization mRNA vaccines were BNT162b2‐mRNA and mRNA‐1273, while non‐mRNA vaccines were ChAdOx1 and BBIBP‐CorV. The booster was mRNA vaccine in every case. COVID, coronavirus disease; mRNA, messenger RNA; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.